How can we outsmart Zika virus?
Authors: Diogo Magnani et.al.
Abstract
The mosquito-transmitted Zika virus has been in the news a lot lately. Do you know what scientists are doing to protect us from it? When the virus infects pregnant women, it can cause neurological defects in their unborn children. Microcephaly (abnormally small heads) is the worst defect caused by Zika. Currently there is no cure or vaccine preventing Zika infection. It is hard to develop a vaccine because of a special feature of this virus and its close relatives called antibody-dependent enhancement. That is why we decided to try a new approach against this virus. Instead of a vaccine, we wanted to introduce “ready-to-go” antibodies that could neutralize the infection. We first found a patient with a natural, strong immune response against Zika virus. We then identified the antibodies that were responsible for this antiviral effect and produced them in the lab. Then, we gave the purified antibodies to four macaques monkeys and injected the animals with Zika virus to see if this treatment can prevent virus replication. Our experiment showed promising results – we found no trace of the virus in the antibodies-treated macaques.
Introduction
Until recently, we thought Zika was a rare and somewhat harmless virus. Similarly to its famous cousins, the West Nile and dengue viruses, Zika gets in your body through a mosquito bite, but you rarely develop any symptoms. When you do, they are usually mild – headaches, a rash, pain in the joints and muscles and a mild fever.
Why should we worry about Zika then?
1. There is evidence that Zika can lead to birth defects. During the big Zika outbreak in Brazil in 2015, thousands of children were born with microcephaly.
2. It is spreading really fast due to climate change and globalization.
There is currently no medicine or vaccine against Zika. In fact, vaccine development for this virus and its cousins is facing a serious problem, called antibody-dependent enhancement. In short, the vaccine produces antibodies that are specific to one virus, but do not block infection of closely related viruses. Instead, the cousin viruses hitchhike on these antibodies to enter the host cells. This often means that the first time a person is infected with a virus, the illness is mild, but when infected with a similar virus later, it is severe and sometimes deadly. That is why we wanted to think of a better way to prevent Zika virus disease without making their cousin virus infections worse. Instead of injecting inactivated Zika viruses that prompt the body to develop antibodies (obtain ‘active immunity’), we wanted to try injecting “ready-to-go” anti-Zika antibodies (‘passive’ immunity) that were modified to prevent disease enhancement.
Available at: <http://www.sciencejournalforkids.org/uploads/5/4/2/8/54289603/zika_article.pdf>. Accessed on: March 28th, 2018 (Adapted).
You shared food with a friend who turned out to have Hepatitis A, a disease you never had. Your doctor suspects you have an infection, so he/she gives you an injection of Immunoglobulin, containing specific hepatitis A virus antibodies. What kind of immunity will this injection induce?
Fonte: FUNDEP · IMEPAC 2018/2 · Questões objetivas.